A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer

Clinical trial NCT04466917 · WITHDRAWN

Trial details

NCT number: NCT04466917
Sponsor: Amgen
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Non-small Cell Lung Cancer (NSCLC)Non-squamous NSCLC

Start date: 2021-05-15
Primary completion: 2022-11-13
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.